Héctor Aviña
Héctor Aviña publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research and Chronic Lymphocytic Leukemia Research.
- World rank
- #1,237,403 of 7,710,434 ranked researchers
- Rank in Japan
- #18,176 of 383,136
- Works
- 91
- Citations
- 1.3k
- Citations per work
- 14.2
What does Héctor Aviña research?
Héctor Aviña's work is mostly in Medicine (59%), Biochemistry, Genetics and Molecular Biology (16%), Engineering (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5358.7%
- Medicine5358.7%
- Everything else1819.7%
- Life Sciences1415.7%
- Physical Sciences55.9%
- Engineering55.9%
- 1Oncology26% of their works
- 2Radiology, Nuclear Medicine and Imaging18% of their works
- 3Molecular Biology16% of their works
- 4Hematology8% of their works
- 5Genetics8% of their works
- 6Mechanical Engineering6% of their works
Research topics
Which keywords describe Héctor Aviña's research?
The keywords of their largest research topics: Glycosylation, Fc Receptors, Therapeutic Antibodies, Breast Cancer, HER2, Chronic Lymphocytic Leukemia, Genomic Aberrations and Immunotherapy.
- Tumor Targeting
- HIF-1
- Genetic Mutations
- Bacterial Therapy
- CAR T Cells
- Immunotherapy
- Chronic Lymphocytic Leukemia
- Breast Cancer
- Fc Receptors
- Glycosylation
- Therapeutic Antibodies
- HER2
- Genomic Aberrations
- Tumor Regression
- Chimeric Antigen Receptor
- Cancer
- Glycans
- Neutropenia
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Glycosylation102 topics
- Fc Receptors91 topic
- Therapeutic Antibodies91 topic
- Breast Cancer61 topic
- HER261 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
- Immunotherapy42 topics
- Tumor Regression42 topics
- CAR T Cells31 topic
- Chimeric Antigen Receptor31 topic
- Bacterial Therapy11 topic
- Cancer11 topic
- Genetic Mutations11 topic
- Glycans11 topic
- HIF-111 topic
- Neutropenia11 topic
- Tumor Targeting11 topic
- Warburg Effect11 topic
Where does Héctor Aviña work?
Héctor Aviña's main affiliation in the publication record is Astellas Pharma (Japan), Japan.
How many publications and citations does Héctor Aviña have?
OpenAlex counts 91 works and 1,293 citations for Héctor Aviña, an h-index of 9, ranking #1,237,403 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Héctor Aviña. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.